This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

CDX-1135

Celldex Therapeutics, Inc.

Drug Names(s): TP10, sCR1

Description: TP-10 is a recombinant soluble complement receptor type 1 (sCR1) that inhibits complement activity.

Partners: Novartis AG


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug